BioMarin Pharmaceutical Inc.
GB ˙ LSE ˙ US09061G1013
54,65 $ ↑0,60 (1,11%)
2026-06-03
DEL PRIS
SecurityGB:0HNC / BioMarin Pharmaceutical Inc.
InstitutionXponance, Inc.
Latest Disclosed Ownership23,028 shares
Latest Disclosed Value $ 1,300,852
Xponance, Inc. reports 28.43% increase in ownership of 0HNC / BioMarin Pharmaceutical Inc.

On May 13, 2026 - Xponance, Inc. filed a 13F-HR form disclosing ownership of 23,028 shares of BioMarin Pharmaceutical Inc. (GB:0HNC) valued at $1,282,660 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 17,930 shares of BioMarin Pharmaceutical Inc.. This represents a change in shares of 28.43% during the quarter. The current value of the position is $1,258,480 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 23,028 5,098 28.43 1,301 22.07 0.0092
2026-02-12 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 17,930 -14,400 -44.54 1,066 -39.14 0.0080
2025-11-12 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 32,330 -12 -0.04 1,751 -1.52 0.0139
2025-08-14 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 32,342 465 1.46 1,778 -21.13 0.0149
2025-05-01 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 31,877 202 0.64 2,253 8.27 0.0218
2025-02-11 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 31,675 2,247 7.64 2,082 0.63 0.0190
2024-11-12 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 29,428 121 0.41 2,068 -14.26 0.0200
2024-08-14 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 29,307 11,709 66.54 2,413 56.93 0.0247
2024-05-13 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 17,598 8,632 96.27 1,537 77.89 0.0161
2024-01-31 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 8,966 -203 -2.21 865 6.54 0.0104
2023-10-24 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 9,169 226 2.53 811 4.65 0.0110
2023-07-14 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 8,943 2,422 37.14 775 22.24 0.0103
2023-04-18 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 6,521 18 0.28 634 -5.65 0.0093
2023-01-24 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 6,503 2,919 81.45 673 121.05 0.0109
2022-10-24 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 3,584 112 3.23 304 5.56 0.0058
2022-08-02 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 3,472 3,472 288 0.0058
2021-11-04 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -2,746 -100.00 0 -100.00
2021-08-12 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 2,746 -14,189 -83.79 229 -82.10 0.0042
2021-05-10 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 16,935 -146 -0.85 1,279 -14.62 0.0271
2021-02-11 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 17,081 71 0.42 1,498 15.77 0.0326
2020-10-26 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 17,010 -21 -0.12 1,294 -38.41 0.0318
2020-08-14 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 17,031 17,031 2,101 0.0542
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.